|
Apr 14
|
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
|
|
Apr 14
|
BMS’ Opdivo combo approved in US for hepatocellular carcinoma
|
|
Apr 11
|
Biotech Stock Bounces From Support, Shows Relative Strength Amid Volatile Market
|
|
Apr 11
|
Is Bristol-Myers Squibb Company (BMY) One of the Best Medical Stocks to Buy According to Billionaires?
|
|
Apr 11
|
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
|
|
Apr 11
|
Bristol-Myers Squibb Investors Likely to Focus on Performance of New Schizophrenia Therapy, UBS Says
|
|
Apr 11
|
3 Value Stocks in the Doghouse
|
|
Apr 10
|
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
|
|
Apr 10
|
The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb
|
|
Apr 9
|
Here's Why Bristol Myers Squibb (BMY) Gained But Lagged the Market Today
|
|
Apr 9
|
Sector Update: Health Care Stocks Gain Late Afternoon
|
|
Apr 9
|
Bristol-Myers Squibb Company (BMY): Among the High Growth Dividend Paying Stocks to Invest in
|
|
Apr 9
|
Bristol-Myers Squibb (NYSE:BMY) Achieves Early FDA Approval for Opdivo Plus Yervoy Therapy
|
|
Apr 9
|
Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More
|
|
Apr 9
|
BMY Gets FDA Nod for Label Expansion of Opdivo plus Yervoy Combo
|
|
Apr 9
|
FDA Approves Bristol Myers' Opdivo Plus Yervoy Combo For Untreated Colorectal Cancer Patients
|
|
Apr 9
|
Trump Says Pharmaceutical Tariffs Coming ‘Very Shortly’
|
|
Apr 8
|
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1
|
|
Apr 8
|
Goldman turns cautious on major pharma names, sees select upside at Eli Lilly
|
|
Feb 17
|
Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy Now
|